Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Rapid Micro Biosystems, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- 0 vs. Q2 2025
- Shares held
- 14.8M
- −316.6K (−2.1%) vs. Q2 2025
- Total value
- $49.5M
- −$2.72M (−5.2%) vs. Q2 2025
- New holders
- 4
- 8 more added
- Sold out
- 4
- 7 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $3 | 0.00% | +1 | New |
| Bank of America Corp | 15 | $50 | 0.00% | −162−91.5% | Reduced |
| SBI Securities Co., Ltd. | 17 | $57 | 0.00% | +2+13.3% | Added |
| JPMorgan Chase & Co | 109 | $364 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 290 | $969 | 0.00% | −8,403−96.7% | Reduced |
| Advisor Group Holdings, Inc. | 300 | $990 | 0.00% | 00.0% | Unchanged |
| Resources Management Corp | 500 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3,626 | $12.1K | 0.00% | +3,626 | New |
| Hudson Bay Capital Management LP | 11,461 | $38.3K | 0.00% | +11,461 | New |
| Legato Capital Management LLC | 14,684 | $49.0K | 0.01% | 00.0% | Unchanged |
| American Century Companies Inc | 16,922 | $56.5K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 20,550 | $68.6K | 0.00% | −15,673−43.3% | Reduced |
| XTX Topco Ltd | 22,165 | $74.0K | 0.00% | −19,635−47.0% | Reduced |
| Jane Street Group, LLC | 38,140 | $127.4K | 0.00% | +38,140 | New |
| Northern Trust Corp | 47,726 | $159.4K | 0.00% | −833−1.7% | Reduced |
| Dimensional Fund Advisors LP | 55,642 | $185.7K | 0.00% | +15,255+37.8% | Added |
| Susquehanna International Group, LLP | 58,387 | $195.0K | 0.00% | +6,528+12.6% | Added |
| Essex Investment Management Co LLC | 62,326 | $208.2K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 91,474 | $305.5K | 0.00% | +31,600+52.8% | Added |
| Renaissance Technologies LLC | 110,187 | $368.0K | 0.00% | −800−0.7% | Reduced |
| Evernest Financial Advisors, LLC | 200,234 | $668.8K | 0.19% | +156,234+355.1% | Added |
| Geode Capital Management, LLC | 204,687 | $683.9K | 0.00% | +608+0.3% | Added |
| BlackRock, Inc. | 483,871 | $1.62M | 0.00% | +7,054+1.5% | Added |
| Advent International Corp | 577,777 | $1.93M | 0.04% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 646,579 | $2.16M | 0.02% | −391,089−37.7% | Reduced |
| Parkman Healthcare Partners LLC | 913,443 | $3.05M | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 965,018 | $3.22M | 0.00% | +60,655+6.7% | Added |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,848,296 | $6.17M | 33.06% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $28.2M | 1.87% | 00.0% | Unchanged |
| EAM Investors, LLC | 0 | $0 | 0.00% | −170,105−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,762−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −20,225−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |